Related Experiment Video
Updated: Jun 23, 2026
06:09
A Three-Dimensional Digital Model for Early Diagnosis of Hepatic Fibrosis Based on Magnetic Resonance Elastography
Published on: July 21, 2023
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis
G V Papatheodoridis1, E Papakonstantinou, E Andrioti
1Hippokration General Hospital, Athens, Greece.
Gut
|February 14, 2003
Summary
Thrombotic risk factors are common in chronic viral hepatitis, with over two-thirds of patients having at least one. The presence of significant risk factors is linked to more advanced liver fibrosis.
Area of Science:
- Hepatology
- Thrombosis Research
- Viral Hepatitis
Background:
- Small intrahepatic vein thrombosis may drive liver tissue remodeling.
- Chronic viral hepatitis is a significant global health concern.
Purpose of the Study:
- To determine the prevalence of thrombotic risk factors in patients with chronic viral hepatitis.
- To investigate the association between these factors and the extent of liver fibrosis.
Main Methods:
- Ninety patients with chronic hepatitis B or C were assessed.
- Evaluation of thrombophilic and coagulation factors alongside liver biopsy.
Main Results:
- 68% of patients had at least one thrombotic risk factor; 37% had two or more.
- Advanced fibrosis (staging scores 4-6) was associated with deficiencies in protein C, antithrombin III, and plasminogen.
- One or more significant thrombotic risk factors independently predicted advanced liver staging (OR 2.4, p=0.02).
Conclusions:
- Thrombotic risk factors are frequently found in chronic viral hepatitis.
- Their presence correlates with more advanced liver fibrosis.
- Further research is needed to clarify the causal relationship and impact on fibrosis progression.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...